drugset / Trial / NCT01056315

A Trial in Painful Diabetic Peripheral Neuropathy With GRT3983Y

NCT01056315 ↗

Phase 2 Terminated 553 enrolled Grünenthal GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

This trial is assessing the analgesic efficacy and safety of a new central analgesic in subjects with pain due to diabetic peripheral neuropathy (DPN).

Timeline

Start
2009-11
Primary completion
2011-01
Completion
2011-01

Outcome

Outcome not reported

Stopped: “Trial was stopped due to difficult enrolment”

Drugs

EvaluationDrugModalityDoseRoute
Subject GRT3983Y Unknown 100 mg —
Subject GRT3983Y Unknown 300 mg —